Molecular classification of the four distinct subtypes of gastric cancer could potentially shape tailored treatment options by helping to predict survival outcomes and patients' response to chemotherapy.
Jul 26, 2017
0
0
Cancer Research UK’s Drug Development Office (DDO), in collaboration with academia and industry, has announced a new trial to open in Oxford.
Aug 17, 2012
0
0
A research team led by Prof. Li Zhicheng from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences (CAS) has developed an artificial intelligence-based model that significantly improves ...
Nov 8, 2023
0
0
German pharmaceuticals maker Merck KGaA said Tuesday it is withdrawing its application for its drug Erbitux to be used to treat patients with lung cancer.
Sep 18, 2012
0
0
Early in the COVID-19 pandemic, widespread cancelations of electively-scheduled or 'non-emergency' operations were implemented to free up hospital beds and conserve protective equipment for health care workers. For some conditions, ...
Jul 7, 2020
0
0
Infection with the stomach-dwelling bacterium Helicobacter pylori— particularly strains producing the oncoprotein CagA—is a strong risk factor for gastric cancer.
Feb 18, 2019
0
0
Overweight adolescents were twice as likely as their normal weight peers to later develop esophageal cancer in a recent study from Israel. The study, which is published early online in Cancer, a peer-reviewed journal of the ...
Oct 14, 2013
0
0
A study by Anna Arnqvist's research group at Umeå University reveals molecular details about the gastric pathogen Helicobacter pylori's ability to bind to an inflamed stomach and how this is controlled by the stomach's pH. ...
Mar 20, 2024
0
0
Researchers at Moffitt Cancer Center studied patients with metastatic gastric cancer and found that those who have both surgery and radiation have better survival than those who receive one or no form of treatment.
Feb 27, 2013
0
0
(HealthDay)—Patients with gastric and gastroesophageal junction (GEJ) cancer who survive for longer than three years after diagnosis seem to have distinct demographic and pathologic characteristics, compared with those ...
Sep 7, 2012
0
0
